THE KPM GROUP DC LLC

Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

Filing 2nd Quarter - Amendment

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $10,000.00 income · posted Jul 28, 2026

Bills named in this filing 4

Lobbying activity 1

Health Issues

HR 5509/S.2903 Safe Step Act HR 6423/S. 864 HELP Copays Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.